How should I manage an 80‑year‑old patient with acute suppurative sialadenitis who is receiving tablet augmentin (amoxicillin‑clavulanate) 1000 mg twice daily and has developed watery diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Antibiotic-Associated Diarrhea in an Elderly Patient with Acute Suppurative Sialadenitis

For an 80+ year-old patient with acute suppurative sialadenitis on augmentin 1000 mg twice daily who develops watery diarrhea, continue the antibiotic while implementing supportive measures, test for C. difficile if diarrhea is moderate-to-severe, and consider switching to twice-daily dosing if not already prescribed.

Immediate Assessment

Classify the diarrhea severity to guide management:

  • Uncomplicated (mild): Watery stools without fever, severe cramping, blood, or signs of dehydration—manage conservatively while continuing antibiotics 1
  • Complicated (moderate-to-severe): Presence of fever, severe cramping (grade 2+ nausea/vomiting), blood in stool, dehydration (dizziness, decreased urine output), or decreased performance status—requires aggressive intervention 1

Assess hydration status by examining:

  • Skin turgor, mucous membrane moisture, orthostatic vital signs (dizziness on standing), mental status changes, and urine output 1

Management Strategy

For Mild, Uncomplicated Diarrhea

Continue augmentin to completion because acute suppurative sialadenitis requires full antibiotic therapy; stopping prematurely risks treatment failure and bacterial resistance 2, 3, 4. The FDA label explicitly states that diarrhea is a common problem caused by antibacterials and usually ends when treatment is discontinued 2.

Implement supportive measures:

  • Increase oral hydration with 8-10 large glasses of clear liquids daily (water, broth, oral rehydration solutions) 1
  • Stop all lactose-containing products, alcohol, and high-osmolar supplements 1
  • Encourage bland, easily digestible foods (bananas, rice, applesauce, toast) 1
  • Consider probiotics to reduce symptom severity, though evidence is stronger in pediatric populations 5

Optimize the augmentin regimen:

  • Ensure the patient is taking augmentin 1000 mg (875/125 mg formulation) twice daily rather than three times daily, as twice-daily dosing reduces gastrointestinal side effects while maintaining efficacy 6
  • Confirm each dose is taken with meals or snacks to minimize GI upset, as recommended by the FDA label 2

For Moderate-to-Severe or Complicated Diarrhea

Test for Clostridioides difficile immediately if the patient has any of the following: fever, severe cramping, bloody stools, or worsening symptoms despite supportive care 1, 6. The Infectious Diseases Society of America recommends testing for C. difficile toxin in all cases of complicated antibiotic-associated diarrhea 6.

Discontinue augmentin immediately if C. difficile is suspected based on clinical presentation (severe diarrhea with fever, cramping, or systemic symptoms) while awaiting test results 6. Do not use empiric antibiotics for the diarrhea itself unless the patient shows signs of sepsis 6.

Provide aggressive supportive care:

  • Administer intravenous fluids if the patient cannot maintain oral hydration or shows signs of dehydration 1
  • Monitor complete blood count and electrolyte profile 1
  • Consider hospitalization for intensive monitoring if outpatient management is inadequate 1

Switch to an alternative antibiotic for sialadenitis if augmentin must be stopped:

  • Consider a fluoroquinolone (levofloxacin 500-750 mg daily) or cephalosporin (ceftriaxone) that provides adequate coverage for the polymicrobial flora of acute suppurative sialadenitis (typically staphylococci and streptococci) 3, 4, 7
  • Avoid azithromycin as first-line replacement due to inadequate coverage for common respiratory pathogens, though it may be considered in specific circumstances 6

Special Considerations for Elderly Patients

Age >80 years is a high-risk factor that warrants closer monitoring and lower threshold for intervention 1, 8. Elderly patients are more likely to develop complications from both the infection and antibiotic side effects 1.

Assess for comorbidities (cirrhosis, chronic kidney disease, heart failure, poorly controlled diabetes) that increase risk of complicated diarrhea and may require hospitalization 1, 8.

Monitor for warning signs requiring immediate medical attention:

  • Fever >101°F (38.3°C), severe uncontrolled abdominal pain, persistent vomiting, inability to maintain oral intake, signs of dehydration (decreased urine output, lethargy, confusion) 1, 8, 5

Duration and Follow-Up

Complete the full antibiotic course for sialadenitis (typically 7-10 days) unless C. difficile or another complication necessitates discontinuation 2, 3, 4. The FDA label emphasizes that skipping doses or not completing therapy decreases effectiveness and increases bacterial resistance 2.

Contact physician if diarrhea is severe or lasts more than 2-3 days, as recommended by the FDA label 2. Persistent symptoms warrant reassessment and possible C. difficile testing even if initially mild 1, 6.

Counsel the patient that watery and bloody stools can develop even 2 or more months after the last antibiotic dose, requiring prompt medical evaluation 2.

Critical Pitfalls to Avoid

  • Do not stop augmentin prematurely for mild diarrhea without consulting the prescribing physician, as incomplete treatment of sialadenitis can lead to abscess formation or chronic infection 2, 3, 4
  • Do not use antimotility agents (loperamide) in elderly patients with antibiotic-associated diarrhea, especially if C. difficile is suspected, as they can precipitate toxic megacolon 1, 9
  • Do not delay C. difficile testing in patients with moderate-to-severe symptoms, fever, or bloody diarrhea, as early diagnosis and treatment improve outcomes 1, 6
  • Do not assume all antibiotic-associated diarrhea is benign; elderly patients are at higher risk for C. difficile infection and severe complications 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Microbiology and Management of Sialadenitis.

Current infectious disease reports, 2002

Research

Salivary gland disorders.

American family physician, 2014

Guideline

Management of Diarrhea in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Amoxicillin-Clavulanate-Associated Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Diverticulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.